Clinical evaluation of novel recombinant glycopegylated FVIII (turoctocog alfa pegol, N8-GP): efficacy and safety in previously treated patients with severe hemophilia A - results of pathfinder (TM) 2 international trial

P. Giangrande,P. Chowdary, S. Enhrenforth,H. Hanabusa,F. W. Leebeek,S. R. Lentz,L. Nemes,L. H. Poulsen, E. Santagostino,C. W. You, W. H. O. Clausen,J. Oldenburg

JOURNAL OF THROMBOSIS AND HAEMOSTASIS(2015)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要